“…With regard to the current technology to fuse antibody-producing B cells with myeloma partner cells, the most popular technique is polyethylene glycol (PEG)-mediated cell fusion. PEG-fusion gives good yields of hybridomas if carefully controlled by following a detailed procedure, but the uncertainty with respect to the outcome of individual experiments still remains because the success of fusion depends, to some extent, on minute details which are difficult to standardize (1,4). Successful improvements of the fusion technique with electrofusion (2, 3, 4) and immunochemical methods (5, 6) have been reported, but none of these techniques have been widely adopted (1).…”